Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2020-07-30
CTLTCatalent, Inc.Lucier Gregory TDirS - Sale$90.09-24,00021,989-52%-$2,162,160
M
2020-07-30
RZLTRezolute, Inc.Handok, Inc.10%P - Purchase$0.32+375,00094,589,5870%+$118,963
D
2020-07-29
BGNEBeigene, Ltd.Huang JaneCMO, HematologyS - Sale+OE$209.93-3,000326,247-1%-$629,787
D
2020-07-24
GNCAGenocea Biosciences, Inc.Glaxosmithkline Plc10%P - Purchase$2.25+1,260,5044,626,389+37%+$2,836,134
2020-07-28
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$17.99+4,10518,032,8590%+$73,849
D
2020-07-29
CYTKCytokinetics IncSchlossberg Mark ASVP - Legal, GCS - Sale+OE$23.07-10,00030,000-25%-$230,728
D
2020-07-28
CYTKCytokinetics IncBlum Robert IPres, CEOS - Sale+OE$23.77-5,000309,034-2%-$118,829
2020-07-28
RTRXRetrophin, Inc.Rosenberg Noah L.Chief Medical OfficerS - Sale$20.49-87026,055-3%-$17,826
2020-07-28
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$17.99+4,10518,032,8590%+$73,849
M
2020-07-28
TYMETyme Technologies, Inc.Hoffman SteveCEO, 10%S - Sale$1.21-95,50026,345,9490%-$115,555
2020-07-28
HGENHumanigen, IncNomis Bay Ltd.10%S - Sale$5.66-10,00032,679,2700%-$56,550
M
2020-07-28
RZLTRezolute, Inc.Handok, Inc.10%P - Purchase$0.33+250,00094,214,5870%+$82,575
D
2020-07-27
FOLDAmicus Therapeutics, Inc.Barth JayChief Medical OfficerS - Sale+OE$15.05-30,000163,224-16%-$451,377
2020-07-27
VNDAVanda Pharmaceuticals Inc.Jones Aranthan IIChief Corp. Affairs OfficerS - Sale$10.62-7,31382,687-8%-$77,631
M
2020-07-27
CCXIChemocentryx, Inc.Vifor (International) Ltd10%S - Sale$52.97-162,4089,331,826-2%-$8,602,072
D
2020-07-28
INZYInozyme Pharma, Inc.Novo Holdings A/s10%P - Purchase$16.00+375,0002,569,379+17%+$6,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Sanofi10%P - Purchase$16.00+81,250520,125+19%+$1,300,000
D
2020-07-28
INZYInozyme Pharma, Inc.Rock Springs Capital Management LP10%P - Purchase$16.00+600,0001,067,884+128%+$9,600,000
2020-07-24
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$42.35-3,351205,576-2%-$141,915
2020-07-28
JNJJohnson & JohnsonMcEvoy AshleyEVP, WW Chair, Medical DevicesS - Sale$147.47-29,00024,433-54%-$4,276,630
D
2020-07-28
INZYInozyme Pharma, Inc.Ra Capital Management, L.P.10%P - Purchase$16.00+600,0002,003,653+43%+$9,600,000
D
2020-07-28
INZYInozyme Pharma, Inc.Sonsini Peter W.10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Sandell Scott D10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Makower Joshua10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Makhzoumi Mohamad10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Florence Anthony A. Jr.10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Baskett Forest10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.New Enterprise Associates 15, L.P.10%P - Purchase$16.00+250,0002,437,689+11%+$4,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Longitude Capital Partners Iii, LLC10%P - Purchase$16.00+625,0002,819,379+28%+$10,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Pivotal Bioventure Partners Fund I, L.P.10%P - Purchase$16.00+187,5001,591,154+13%+$3,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Hopfner Robert LorneDir, 10%P - Purchase$16.00+187,5001,591,154+13%+$3,000,000
D
2020-07-28
INZYInozyme Pharma, Inc.Sofinnova Venture Partners X, L.P.10%P - Purchase$16.00+437,5002,028,308+28%+$7,000,000
M
2020-07-24
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$17.93+72,58318,028,7540%+$1,301,643
M
2020-07-24
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$17.93+72,58318,028,7540%+$1,301,643
D
2020-07-27
URGNUrogen Pharma Ltd.Pfreundschuh Peter P.CFOS - Sale+OE$23.51-1417,355-2%-$3,315
D
2020-07-27
URGNUrogen Pharma Ltd.Schoenberg MarkChief Medical OfficerS - Sale+OE$23.51-7018,5430%-$1,646
A
2020-07-27
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$1.22-20,00025,418,5460%-$24,400
D
2020-07-27
MGNXMacrogenics IncRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$25.47-4,48944,468-9%-$114,319
2020-07-27
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$1.22-20,00025,418,5460%-$24,430
D
2020-07-28
ANNXAnnexon, Inc.Bain Capital Life Sciences Investors, LLC10%P - Purchase$17.00+400,0003,241,628+14%+$6,800,000
2020-07-28
ANNXAnnexon, Inc.Lew JenniferEVP, CFOP - Purchase$17.00+2,0002,000New+$34,000
D
2020-07-28
ANNXAnnexon, Inc.Satter Muneer ADirP - Purchase$17.00+200,0001,954,978+11%+$3,400,000
D
2020-07-28
ANNXAnnexon, Inc.Flynn James EPossible Member of 10% Group, 10%P - Purchase$17.00+700,0001,617,828+76%+$11,900,000
M
2020-07-24
RZLTRezolute, Inc.Handok, Inc.10%P - Purchase$0.33+250,00093,964,5870%+$81,500
2020-07-24
ACERAcer Therapeutics Inc.Aselage SteveDirP - Purchase$3.50+45,00063,905+238%+$157,500
2020-07-24
ACERAcer Therapeutics Inc.Dunn John MichaelDirP - Purchase$3.50+21,42827,380+360%+$74,998
2020-07-24
ACERAcer Therapeutics Inc.Joseph DonaldGC, SecyP - Purchase$3.50+14,28514,285New+$49,998
2020-07-24
ACERAcer Therapeutics Inc.Schelling ChrisPres, CEO, 10%P - Purchase$3.50+142,8571,892,857+8%+$500,000
2020-07-24
RAPTRapt Therapeutics, Inc.Robbins WendyeDirP - Purchase$22.47+9005,450+20%+$20,225
2020-07-23
ABUSArbutus Biopharma CorpMcElhaugh Michael J.Chief Business OfficerS - Sale$5.01-20,0001,367,457-1%-$100,200
D
2020-07-23
ABTAbbott LaboratoriesNovakovic Phebe NDirS - Sale+OE$100.78-93331,113-3%-$94,026
M
2020-07-22
CCXIChemocentryx, Inc.Vifor (International) Ltd10%S - Sale$54.62-133,0749,494,234-1%-$7,267,902
2020-07-22
MACKMerrimack Pharmaceuticals IncCrocker Gary LSee RemarksS - Sale$3.08-193,5090-100%-$596,465
2020-07-22
MACKMerrimack Pharmaceuticals IncAndersen EricSee remarksP - Purchase$3.11+177,274227,182+355%+$552,086
2020-07-22
MACKMerrimack Pharmaceuticals IncLevy Noah G.See remarksP - Purchase$3.11+177,274580,515+44%+$552,087
A
2020-06-29
HOOKHookipa Pharma Inc.Sofinnova Capital VI Fcpr10%S - Sale$11.78-3,2803,960,5740%-$38,628
2020-07-22
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale$42.31-5,626297,914-2%-$238,025
M
2020-07-22
RZLTRezolute, Inc.Handok, Inc.10%P - Purchase$0.29+437,00093,714,5870%+$127,261
D
2020-07-22
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$18.00+19317,912,1710%+$3,474
D
2020-07-22
NGMNgm Biopharmaceuticals IncColumn Group L PDir, 10%P - Purchase$18.00+19317,912,1710%+$3,474
2020-07-22
FREQFrequency Therapeutics, Inc.Loose Christopher R.Chief Scientific OfficerS - Sale$21.51-4,500161,782-3%-$96,791
2020-07-22
ABTAbbott LaboratoriesAustin Roxanne SDirS - Sale$99.80-6,84440,043-15%-$683,038
D
2020-07-21
ABTAbbott LaboratoriesPederson Michael JSVPS - Sale+OE$98.00-23,00871,454-24%-$2,254,784
D
2020-07-21
ONCTOncternal Therapeutics, Inc.Kisner Daniel LDirP - Purchase$2.38+10,00010,000New+$23,825
D
2020-07-21
ONCTOncternal Therapeutics, Inc.Aker Hazel MLegal CounselP - Purchase$2.38+41,97251,271+451%+$99,998
D
2020-07-21
PANDPandion Therapeutics, Inc.Mutz MitchellDir, 10%P - Purchase$18.00+46,1113,096,084+2%+$829,998
D
2020-07-21
ONCTOncternal Therapeutics, Inc.Shanghai Pharmaceutical (Usa) Inc.10%P - Purchase$2.38+1,049,3173,544,431+42%+$2,499,998
2020-07-22
ALBOAlbireo Pharma, Inc.Duncan JasonGC, GCS - Sale$25.80-914,370-2%-$2,348
2020-07-22
ALBOAlbireo Pharma, Inc.Horn Patrick TaylorChief Medical OfficerS - Sale$25.80-914,374-2%-$2,348
DM
2020-07-20
APLTApplied Therapeutics Inc.Shendelman ShoshanaPres, CEO, 10%S - Sale+OE$26.68-45,0004,884,776-1%-$1,200,789
2020-07-20
GWPHGw Pharmaceuticals PlcKnappertz VolkerChief Medical OfficerS - Sale$11.42-6,00053,940-10%-$68,520
DM
2020-07-20
AMPHAmphastar Pharmaceuticals, Inc.Liawatidewi YakobEVP Corp Admin CenterS - Sale+OE$21.14-10,16448,455-17%-$214,884
2020-07-22
BGNEBeigene, Ltd.Oyler JohnCEOS - Sale$238.34-27,74861,260,7030%-$6,613,503
M
2020-07-20
BGNEBeigene, Ltd.Oyler JohnCEOS - Sale$251.84-55,17561,621,4270%-$13,895,479
2020-07-20
FREQFrequency Therapeutics, Inc.Marcus Joel SDirP - Purchase$18.00+55,5551,331,430+4%+$999,990
D
2020-07-22
HZNPHorizon Therapeutics Public Ltd CoGrey Michael GDirS - Sale+OE$60.00-1,75562,290-3%-$105,300
D
2020-07-20
BMRNBiomarin Pharmaceutical IncFuchs Henry JPres, Worldwide R, DS - Sale+OE$130.00-126,389102,995-55%-$16,430,570
2020-07-20
BGNEBeigene, Ltd.Wang XiaodongChair, Scientific Advisory BrdS - Sale$251.51-17,00011,940,9890%-$4,275,636
D
2020-07-21
REGNRegeneron Pharmaceuticals, Inc.Fenimore Christopher R.VP ControllerS - Sale+OE$642.04-3,70923,623-14%-$2,381,317
D
2020-07-21
REGNRegeneron Pharmaceuticals, Inc.Landry Robert EEVP Finance CFOS - Sale+OE$647.58-39124,871-2%-$253,204
D
2020-07-21
PANDPandion Therapeutics, Inc.Ra Capital Management, L.P.10%P - Purchase$18.00+361,1111,770,023+26%+$6,499,998
D
2020-07-21
ALXOAlx Oncology Holdings IncLsv Associates, LLC10%P - Purchase$19.00+400,000120,212-143%+$7,600,000
D
2020-07-21
PANDPandion Therapeutics, Inc.Glaxosmithkline PlcDir, 10%P - Purchase$18.00+361,1112,248,304+19%+$6,499,998
M
2020-07-20
IMUXImmunic, Inc.Groeppel ManfredCOOS - Sale$14.58-5,650278,830-2%-$82,355
M
2020-07-20
IMUXImmunic, Inc.Vitt DanielCEOS - Sale$14.68-6,300362,877-2%-$92,510
2020-06-29
HOOKHookipa Pharma Inc.Sofinnova Capital VI Fcpr10%S - Sale$11.78-3,2803,960,5740%-$38,628
2020-07-20
HOOKHookipa Pharma Inc.Sofinnova Capital VI Fcpr10%S - Sale$11.94-12,4833,948,0910%-$149,102
2020-07-21
RZLTRezolute, Inc.Handok, Inc.10%P - Purchase$0.25+250,00093,277,5870%+$63,150
D
2020-07-21
ALXOAlx Oncology Holdings IncLettmann JasonDir, 10%P - Purchase$19.00+400,000227,432-232%+$7,600,000
D
2020-07-21
ALXOAlx Oncology Holdings IncAdelman Robert JSee Remarks, 10%P - Purchase$19.00+853,0005,829,542+17%+$16,207,000
D
2020-07-21
ALXOAlx Oncology Holdings IncVivo Capital Ix, LLC10%P - Purchase$19.00+975,000185,526-123%+$18,525,000
D
2020-07-21
ALXOAlx Oncology Holdings IncGraham G. WalmsleyDirP - Purchase$19.00+975,000975,000New+$18,525,000
2020-07-21
ALXOAlx Oncology Holdings IncHemrajani RekhaDirP - Purchase$19.00+3,0003,000New+$57,000
D
2020-07-21
ALXOAlx Oncology Holdings IncGoodman Corey SExecutive Chairman, 10%P - Purchase$19.00+850,000515,894-254%+$16,150,000
2020-07-20
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$1.24-20,00025,438,5460%-$24,756
2020-07-21
ALXOAlx Oncology Holdings IncPietzke SteffenVP Fin, Chief Acct OfficerP - Purchase$19.00+3,0003,000New+$57,000
2020-07-21
ALXOAlx Oncology Holdings IncGarcia Peter SCFOP - Purchase$19.00+3,0003,000New+$57,000
D
2020-07-21
PANDPandion Therapeutics, Inc.Polaris Partners Gp Viii, L.L.C.10%P - Purchase$18.00+36,111110,621+48%+$649,998
D
2020-07-21
PANDPandion Therapeutics, Inc.Boxer Capital, LLC10%P - Purchase$18.00+722,2222,131,135+51%+$12,999,996
D
2020-07-21
PANDPandion Therapeutics, Inc.Carroll JillDir, 10%P - Purchase$18.00+361,1112,248,304+19%+$6,499,998
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top